rs11594656

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The variant allele was found at a frequency of 0.183 in 152,076 control chromosomes in the GnomAD database, including 3,369 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).

Frequency

Genomes: 𝑓 0.18 ( 3369 hom., cov: 32)

Consequence

Unknown

Scores

2

Clinical Significance

Likely benign no assertion criteria provided B:1O:1

Conservation

PhyloP100: 0.206

Publications

89 publications found
Variant links:

Genome browser will be placed here

ACMG classification

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 10-6080046-T-A is Benign according to our data. Variant chr10-6080046-T-A is described in ClinVar as Likely_benign. ClinVar VariationId is 14670.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.249 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt

Frequencies

GnomAD3 genomes
AF:
0.183
AC:
27786
AN:
151958
Hom.:
3366
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0514
Gnomad AMI
AF:
0.228
Gnomad AMR
AF:
0.229
Gnomad ASJ
AF:
0.395
Gnomad EAS
AF:
0.0214
Gnomad SAS
AF:
0.187
Gnomad FIN
AF:
0.169
Gnomad MID
AF:
0.379
Gnomad NFE
AF:
0.253
Gnomad OTH
AF:
0.243
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.183
AC:
27791
AN:
152076
Hom.:
3369
Cov.:
32
AF XY:
0.178
AC XY:
13251
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.0513
AC:
2129
AN:
41490
American (AMR)
AF:
0.228
AC:
3484
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.395
AC:
1370
AN:
3472
East Asian (EAS)
AF:
0.0214
AC:
111
AN:
5180
South Asian (SAS)
AF:
0.187
AC:
902
AN:
4814
European-Finnish (FIN)
AF:
0.169
AC:
1785
AN:
10562
Middle Eastern (MID)
AF:
0.401
AC:
117
AN:
292
European-Non Finnish (NFE)
AF:
0.253
AC:
17169
AN:
67982
Other (OTH)
AF:
0.244
AC:
516
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1086
2172
3259
4345
5431
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
300
600
900
1200
1500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.222
Hom.:
619
Bravo
AF:
0.182
Asia WGS
AF:
0.116
AC:
404
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

IL2RA-related disorder Benign:1
Feb 27, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Type 1 diabetes mellitus 10 Other:1
Apr 17, 2025
OMIM
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
8.4
DANN
Benign
0.77
PhyloP100
0.21

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11594656; hg19: chr10-6122009; API